C M Bidwell & Associates LTD Lantheus Holdings, Inc. Transaction History

C M Bidwell & Associates LTD

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$60.27 - $90.75 $49,120 - $73,961	-815 Reduced 95.88%	35 $2,000
Q2 2023 Aug 11, 2023	SELL	$82.41 - $99.65 $3,955 - $4,783	-48 Reduced 5.35%	850 $71,000
Q1 2023 May 11, 2023	BUY	$47.76 - $82.86 $573 - $994	12 Added 1.35%	898 $74,000
Q4 2022 Feb 10, 2023	SELL	$48.76 - $77.67 $101,615 - $161,864	-2,084 Reduced 70.17%	886 $45,000
Q3 2022 Nov 14, 2022	BUY	$61.42 - $86.29 $15,047 - $21,141	245 Added 8.99%	2,970 $209,000
Q2 2022 Aug 12, 2022	BUY	$55.54 - $72.65 $151,346 - $197,971	2,725 New	2,725 $180,000
Q3 2019 Nov 13, 2019	SELL	$21.01 - $28.94 $37,502 - $51,657	-1,785 Closed	0 $0
Q2 2019 Aug 07, 2019	SELL	$23.33 - $28.3 $1,166 - $1,415	-50 Reduced 2.72%	1,785 $51,000
Q1 2019 May 15, 2019	BUY	$14.93 - $25.1 $27,396 - $46,058	1,835 New	1,835 $45,000

539

69.9M

651K

459K

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $5.63B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

Get notified when there are updates to the investment portfolio of C M Bidwell & Associates LTD, based on Form 13F filings with the SEC.

Stay updated on C M Bidwell & Associates LTD with notifications on news.